| Code |
Name |
CAS No |
Remark |
| 20143 |
Imatinib |
152459-95-5 |
Bulk goods, imatinib intermediates |
| 20144 |
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine |
161599- 46-8 |
Bulk, capecitabine intermediate |
| 20145 |
3-Thiophenecarboxylic acid, 2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-4-[(dimethylamino)methyl]-5-(4-nitrophenyl)-, ethyl ester |
2591260-08-9 |
Relugolix |
| 20146 |
Relugolix |
737789-87-6 |
Relugolix |
| 20147 |
Crizotinib |
877399-52-5 |
Crizotinib |
| 20148 |
Lorlatinib |
1454846-35-5 |
Lorlatinib |
| 20149 |
Osimertinib mesylate |
1421373-66-1 |
Osimertinib |
| 20150 |
Selpercatinib |
2152628-33-4 |
Cicatinib |
| 20151 |
Acalabrutinib |
1420477-60-6 |
Acalatinib |
| 20152 |
Capmatinib |
1029712-80-8 |
Capmatinib |
| 20153 |
Larotrectinib |
1223403-58-4 |
Larotrectinib |
| 20154 |
Brigatinib |
1197953-54-0 |
Brigatinib |
| 20155 |
Olaparib |
763113-22-0 |
Olapani |
| 20156 |
Filgotinib |
1206161-97-8 |
Filgotinib |
| 20157 |
Sunitinib Malate |
341031-54-7 |
Sunitinib malate |
| 20158 |
Sunitinib |
557795-19-4 |
Sunitinib |
| 20159 |
N,N,N'-Trimethylethanediamine |
142-25-6 |
Osimertinib intermediate |
| 20160 |
4-Fluoro-2-methoxy-5-nitroaniline |
1075705-01-9 |
Osimertinib intermediate |
| 20161 |
3-(2-Chloropyrimidin-4-yl)-1-methylindole |
1032452-86-0 |
Osimertinib intermediate |
| 20162 |
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine |
1421372-94-2 |
Osimertinib intermediate |
| 20163 |
N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine |
1421372-67-9 |
Osimertinib intermediate |
| 20164 |
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine |
1421372-66-8 |
Osimertinib intermediate |
| 20165 |
tert-Butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate |
877399-73-0 |
Crizotinib intermediate |
| 20166 |
tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate |
877399-74-1 |
Crizotinib intermediate |
| 20167 |
(S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol |
877397-65-4 |
Crizotinib intermediate |
| 20168 |
(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine |
877397-71-2 |
Crizotinib intermediate |
| 20169 |
(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine |
877399-00-3 |
Crizotinib intermediate |
| 20170 |
(R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate |
877399-51-4 |
Crizotinib intermediate |
| 20171 |
5-(Trifluoromethyl)uracil |
54-20-6 |
Trifluridine intermediate |
| 20172 |
2-Bromo-5-hydroxybenzaldehyde |
2973-80-0 |
Crisaborole intermediate |
| 20173 |
4-(4-Bromo-3-formylphenoxy)benzonitrile |
906673-54-9 |
Crisaborole intermediate |
| 20174 |
4-(4-bromo-3-(hydroxymethyl)phenoxy)benzonitrile |
906673-45-8 |
Crisaborole intermediate |
| 20175 |
5-Fluoro-2-oxindole |
56341-41-4 |
Sunitinib intermediate |
| 20176 |
Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
2199-59-9 |
Sunitinib intermediate |
| 20177 |
5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid |
253870-02-9 |
Sunitinib intermediate |
| 20178 |
N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide |
356068-86-5 |
Sunitinib intermediate |
| 20179 |
(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol |
1454847-96-1 |
Lorlatinib intermediate |
| 20180 |
Methyl (R)-2-(1-((2-aminopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate |
1454847-99-4 |
Lorlatinib intermediate |
| 20181 |
Methyl (R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate |
1454848-00-0 |
Lorlatinib intermediate |
| 20182 |
2-[(1R)-1-[[2-[bis[(1,1-dimethylethoxy)carbonyl]amino]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]oxy]ethyl]-4-flu... |
1454851-42-3 |
Lorlatinib intermediate |
| 20183 |
tert-Butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate |
1454848-24-8 |
Lorlatinib intermediate |
| 20184 |
(S)-5-fluoro-3-methylisobenzofuran-1(3H)-one |
1803573-19-4 |
Lorlatinib intermediate |
| 20185 |
1-Methyl-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile hydrochloride |
1643141-20-1 |
Lorlatinib intermediate |
| 20186 |
2-(Bis(tert-butoxycarbonyl)amino)-5-bromopyridin-3-yl-4-methylbenzenesulfonate |
1803573-21-8 |
Lorlatinib intermediate |
| 20187 |
Ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate |
174072-89-0 |
Relugolix intermediate |
| 20188 |
2-((ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate |
308831-93-8 |
Relugolix intermediate |
| 20189 |
Ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate |
308831-94-9 |
Relugolix intermediate |
| 20190 |
2-((2,6-Difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid |
1589503-95-6 |
Relugolix intermediate |
| 20191 |
Ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylate |
1589503-97-8 |
Relugolix intermediate |
| 20192 |
4-Cyano-3-fluorophenylboronic acid pinacol ester |
870238-67-8 |
Capmatinib intermediate |
